The purpose of this website is to support healthcare professionals in their daily practice for the pandemic influenza. It aims to provide information as an aid to treatment. The website provides healthcare professionals with information on GSK products for pandemic influenza and the opportunity to report adverse events
Relenza™ and Relenza Rotacaps™ (zanamivir) are indicated for treatment of both influenza A and B in adults and children (≥5 years) who present with symptoms typical of influenza when influenza is circulating in the community...
Pandemrix™ (H1N1) (pandemic influenza vaccine [H1N1]) is indicated for the prophylaxis of influenza in an officially declared pandemic situation.